IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.
Reid
John M
JM
Gubitz
Gordon J
GJ
Phillips
Stephen J
SJ
D000208:Acute Disease; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015986:Confounding Factors, Epidemiologic; D042241:Early Diagnosis; D004632:Emergency Medical Services / Q000592:standards / Q000706:statistics & numerical data*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008824:Michigan / Q000453:epidemiology; D008875:Middle Aged; D009674:Nova Scotia / Q000453:epidemiology; D012042:Registries; D017678:Sex Distribution; D012737:Sex Factors; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator